Successful Treatment of Late Onset Infection Due to Multi-Drug Resistant Acinetobacter Lwoffii in a Low Birth Weight Neonate Using Ciprofloxacin

URAIWAN CHOTIGEAT,M.D.*, MEERA KHORANA, M.D.*, NARIS WARANAWAT,M.D.**

Affiliation : * Neonatal Unit, ** Infectious Unit, Pediatrics Department, Queen Sirikit National Institute of Child Health, Bangkok I 0400, Thailand.

AbstractThis report presents the case of a low birth weight neonate with multidrug-resistant Acinetobacter Lwoffii infection who was successfully treated with ciprotloxacin and co-trimoxazole. Use of ciprotloxacin in pediatric populations was reviewed. The infant responded to the antibiotic regimen with sterilized cerebrospinal fluid with no adverse effects attributable to the ciprofloxacin. Although ciprofloxacin has been found to cause irreversible damage to cartilage in laboratory animals, a review of the literature found that this complication rarely occurs in pediatric patients. Ciprotloxacin has been found to be effective in the treatment of multidrug-resistant gram negative infections in pediatric patients, including premature infants. Ciprofloxacin should be considered in the treatment of neonatal infection caused by multidrug-resistant gram-negative organisms.

Keywords : Acinetobacter Lwoffii, Low Birth Weight, Ciprofloxacin

All Articles Download

Information

Related Links